ß-receptor antagonists. Pharmaceuticals having a high affinity for adrenergic ß-receptors, whereby they can displace the physiological mediators adrenaline and noradrenaline without exerting their effect, unlike effective ß-receptor agonists. A distinction is made between ß1-selective beta-blockers and non-selective beta-blockers, which influence ß1- and ß2-receptors equally.